# Lilly del Caribe, Inc - Inspection Records

Source: https://www.keypedia.com/companies/lilly-del-caribe-inc/5091d4cf-a496-46ba-96aa-da9dbb686073

> Inspection records and compliance data for Lilly del Caribe, Inc in Carolina, Puerto Rico. Access full analysis and detailed observations.

---

## Details

- Name: Lilly del Caribe, Inc
- FEI Number: 2619243
- City: Carolina
- State: Puerto Rico
- Country Name: United States
- Address Line 1: 12.6 Km 65th Infantry Road (Pr01)
- Zip Code: 00985

## Related Documents

- [483 - Lilly del Caribe, Inc - 2026-01-30](https://www.keypedia.com/records/483/lilly-del-caribe-inc/ec06632e-9749-4768-ba9f-878d601b6ada) — source: FDA, date: January 30, 2026
- [FDA Inspection 1300794 - Lilly del Caribe, Inc - 2026-01-30](https://www.keypedia.com/records/fda_inspections/lilly-del-caribe-inc/d9a41b15-225e-4c51-bfaf-91cb7e3c3d83) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 30, 2026
- [483 - Lilly del Caribe, Inc - 2022-02-25](https://www.keypedia.com/records/483/lilly-del-caribe-inc/46c27262-2d1c-43db-8d65-648ca4b97af0) — source: FDA, date: February 25, 2022
- [FDA Inspection 1163359 - Lilly del Caribe, Inc - 2022-02-25](https://www.keypedia.com/records/fda_inspections/lilly-del-caribe-inc/67a137fe-39cd-4944-a803-b07d21b0597d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 25, 2022
- [FDA Inspection 1097298 - Lilly del Caribe, Inc - 2019-07-12](https://www.keypedia.com/records/fda_inspections/lilly-del-caribe-inc/a1a425a8-d9bf-46ef-9ec7-8b7fd47ad3fa) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 12, 2019
- [483 - Lilly del Caribe, Inc - 2019-07-09](https://www.keypedia.com/records/483/lilly-del-caribe-inc/ee2ef5e0-3458-4860-bbd6-0073979267c9) — source: FDA, date: July 9, 2019
- [483 - Lilly del Caribe, Inc - 2018-09-21](https://www.keypedia.com/records/483/lilly-del-caribe-inc/ce0b5072-f84a-409e-b147-2a40ff94b035) — source: FDA, date: September 21, 2018
- [FDA Inspection 1069938 - Lilly del Caribe, Inc - 2018-09-21](https://www.keypedia.com/records/fda_inspections/lilly-del-caribe-inc/7a1e89bb-7296-474d-b52c-d1cb38dfd3bc) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 21, 2018
- [FDA Inspection 1020761 - Lilly del Caribe, Inc - 2017-07-21](https://www.keypedia.com/records/fda_inspections/lilly-del-caribe-inc/d181624a-29e4-42de-b068-e183bfe32f1b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 21, 2017
- [FDA Inspection 927312 - Lilly del Caribe, Inc - 2015-05-01](https://www.keypedia.com/records/fda_inspections/lilly-del-caribe-inc/6547a79e-d33f-4ba7-b48a-eb9479700491) — classification: No Action Indicated (NAI), source: FDA, date: May 1, 2015
- [483 - Lilly del Caribe, Inc - 2013-07-23](https://www.keypedia.com/records/483/lilly-del-caribe-inc/0c58a251-c690-4739-9d0d-2098e0f0ec8e) — source: FDA, date: July 23, 2013
- [FDA Inspection 841121 - Lilly del Caribe, Inc - 2013-07-22](https://www.keypedia.com/records/fda_inspections/lilly-del-caribe-inc/f9ff1cac-a5f1-46f1-a101-4a7582334a19) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 22, 2013
- [FDA Inspection 681591 - Lilly del Caribe, Inc - 2010-09-23](https://www.keypedia.com/records/fda_inspections/lilly-del-caribe-inc/425c6297-712c-4da6-b2be-7492e5405356) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 23, 2010

## Related Companies

- [Aurobindo Pharma Limited](https://www.keypedia.com/companies/aurobindo-pharma-limited/95bcc3b3-09a1-4249-af2f-5c83de789b76)
- [Valneva Scotland Ltd.](https://www.keypedia.com/companies/valneva-scotland-ltd/7e6970c2-c9dd-4c5d-9d35-725121b6e877)
- [Pyramid Laboratories, Inc.](https://www.keypedia.com/companies/pyramid-laboratories-inc/28e777be-a530-400a-97c6-9780ede4fb33)
- [Aurobindo Pharma Limited](https://www.keypedia.com/companies/aurobindo-pharma-limited/526fd1b4-90b1-4e91-b9f5-a3eab997ed60)
- [Nippon Fine Chemical Co., Ltd.](https://www.keypedia.com/companies/nippon-fine-chemical-co-ltd/6b21c73b-4779-42c3-b0f6-64179f8de3a2)
- [Chugai Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/chugai-pharmaceutical-co-ltd/5261bb2e-233a-40e3-8aa3-3e7b0b70dd29)
- [BRS Analytical Services, LLC](https://www.keypedia.com/companies/brs-analytical-services-llc/841b237e-76fe-4854-a862-802339b3e528)
- [Unilever Manufacturing (US), Inc.](https://www.keypedia.com/companies/unilever-manufacturing-us-inc/ae587d51-1cf8-4ced-af22-8da0d2758cf6)
- [Apertus Pharmaceuticals](https://www.keypedia.com/companies/apertus-pharmaceuticals/7436af25-9f52-43d1-a68e-002922496155)
- [Shionogi Pharma Co., Ltd.](https://www.keypedia.com/companies/shionogi-pharma-co-ltd/97a7893d-fd4c-45bc-9237-0e03e7d8af7c)

## Related Officers

- [Libia Lugo](https://www.keypedia.com/people/libia-lugo/55f1387e-b6bd-41ca-8507-45829629dac5)
- [Investigator ](https://www.keypedia.com/people/raquel-gonzalez-rivera/84cdd41f-b03c-4d13-a289-e2ebf4417c3c)
- [Investigator](https://www.keypedia.com/people/noreen-muniz/0bb20d12-62ad-42aa-8b0a-c44b339d413f)
- [investigator](https://www.keypedia.com/people/marian-e-ramirez/4b718b67-fee0-488c-9354-ee366d3510ad)
- [Quality System Specialist](https://www.keypedia.com/people/jose-e-melendez/75bd6083-14a4-4bd2-a0e5-9946d4dd37e1)